AGL 36.95 Decreased By ▼ -1.05 (-2.76%)
AIRLINK 215.48 Increased By ▲ 1.57 (0.73%)
BOP 9.47 Increased By ▲ 0.05 (0.53%)
CNERGY 6.47 Increased By ▲ 0.18 (2.86%)
DCL 8.57 Decreased By ▼ -0.20 (-2.28%)
DFML 40.62 Decreased By ▼ -1.59 (-3.77%)
DGKC 99.10 Increased By ▲ 4.98 (5.29%)
FCCL 36.38 Increased By ▲ 1.19 (3.38%)
FFBL 88.94 No Change ▼ 0.00 (0%)
FFL 17.12 Increased By ▲ 0.73 (4.45%)
HUBC 126.39 Decreased By ▼ -0.51 (-0.4%)
HUMNL 13.35 Decreased By ▼ -0.02 (-0.15%)
KEL 5.23 Decreased By ▼ -0.08 (-1.51%)
KOSM 6.74 Decreased By ▼ -0.20 (-2.88%)
MLCF 44.18 Increased By ▲ 1.20 (2.79%)
NBP 59.69 Increased By ▲ 0.84 (1.43%)
OGDC 222.29 Increased By ▲ 2.87 (1.31%)
PAEL 40.55 Increased By ▲ 1.39 (3.55%)
PIBTL 8.05 Decreased By ▼ -0.13 (-1.59%)
PPL 191.40 Decreased By ▼ -0.26 (-0.14%)
PRL 38.68 Increased By ▲ 0.76 (2%)
PTC 27.00 Increased By ▲ 0.66 (2.51%)
SEARL 103.90 Decreased By ▼ -0.10 (-0.1%)
TELE 8.60 Increased By ▲ 0.21 (2.5%)
TOMCL 35.00 Increased By ▲ 0.25 (0.72%)
TPLP 13.70 Increased By ▲ 0.82 (6.37%)
TREET 24.94 Decreased By ▼ -0.40 (-1.58%)
TRG 72.00 Increased By ▲ 1.55 (2.2%)
UNITY 33.40 Increased By ▲ 0.01 (0.03%)
WTL 1.71 Decreased By ▼ -0.01 (-0.58%)
BR100 11,975 Increased By 81.1 (0.68%)
BR30 37,066 Increased By 211.6 (0.57%)
KSE100 111,376 Increased By 952.4 (0.86%)
KSE30 35,040 Increased By 261.7 (0.75%)

A cure for all types of cancer could be available on the NI-IS within five years, say scientists in Manchester. The world's first patient trials in a technique which genetically engineers cells will take place at the city's Christie Hospital later this year. According to BBC, the treatment gene-modified t-cell therapy could replace more intrusive treatments like chemotherapy. The cells are fitted with a "tracker" device to kill cancer cells before being injected back into the patient.
Professor Robert Hawkins, clinical director of Medical oncology at the hospital, says the initial results of lab tests have been "spectacular".
More traditional treatments like radiotherapy and chemotherapy destroy both healthy and cancerous cells. The new system makes the body naturally seek out and kill tumours by boosting the infection-fighting t-cells.
The body does not naturally have enough of these cells to combat huge tumours, and cancer cells often develop protective mechanisms to avoid them being recognised by the body as a disease.
Doctors will take blood samples from cancer patients to extract t-cells. They then genetically modify the t-cells, attaching an antibody, which works like a tracking device to enable the t-cells to zone in on cancer tumours.

Copyright Associated Press of Pakistan, 2005

Comments

Comments are closed.